Nearly seven days after David Einhorn announced his short attack on Athenahealth, Inc (NASDAQ:ATHN), a Morgan Stanley report doesn’t mention the incident in its May 12 research note on the stock. Athenahealth: Morgan “overweight,” notes potential for cost savings in sales, R&D The report, which has Athenahealth, Inc (NASDAQ:ATHN) as an “overweight” in the portfolio, noted that “Steady state margins reflect the underlying earnings power of a mature company no longer investing in growth, characterized by lower R&D and sales & marketing spend.” Although the research note “do not expect it to reach maturity any time soon,” it did say that…
Morgan Stanley Ignores Einhorn, Remains Positive On Athenahealth, Inc
Mark Melin
Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.